Loading...
Loading...
Latest 10-Q filed 10/30/2024 · Compared against 8/1/2024
Chat is set up on each filing report page.
Ask about this filing, its industry, or sector trends.
AI responses are generated from filing and peer context and may contain errors.
ITEM 1A. RISK FACTORS
In addition to the risks discussed below, important risk factors that could cause results or events to differ from current expectations are described in Part I, Item 1A Risk Factors of the Companys Annual Report on FormForm 10-K 10-K for the year ended December 31, 2023 filed with the SEC on February 15, 2024 (the Annual Report).
Our financial results could be negatively affected if a significant portfolio investment fails to perform as expected.
Our total investment in companies may be significant individually or in the aggregate. As a result, if a significant investment in one or more companies fails to perform as expected, our financial results could be more negatively affected, and the magnitude of the loss could be more significant than if we had made smaller investments in more companies. The following table shows the fair value of the totals of investments held in portfolio companies as of JuneSeptember 30, 2024 that represent greater than 5% of our net assets:
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands) |
| ||||||||||
| Fair Value |
| Percentage of Net Assets | ||||||||
Axsome Therapeutics, Inc. | $ | 16 |
|
| 8. | % | |||||
Phathom Pharmaceuticals, Inc. | $ | 1 |
|
| 8. | % | |||||
Marathon Health, LLC | $ | 15 |
|
| 8. | % | |||||
Corium, Inc. | $ | 110, |
|
|
| % | |||||
SeatGeek, Inc. | $ | 10 |
|
| 5. | % | |||||
|
|
|
|
|
|
|
|
|
|
|
|
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for the management of central nervous system disorders for which there are limited treatment options.
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders.
Marathon Health, LLC is a provider of employer-sponsored healthcare platform intended to provide convenient and unhurried patient-centered care services.
Corium, Inc. develops, engineers, and manufactures drug delivery products and devices that utilize the skin and mucosa as a primary means of transport.
SeatGeek, Inc. is a mobile-focused ticket platform that enables users to buy and sell tickets for live sports, concerts and theater events.
Our financial results could be materially adversely affected if these portfolio companies or any of our other significant portfolio companies encounter financial difficulty and fail to repay their obligations or to perform as expected.
889